Search This Blog

Friday, September 1, 2023

NYC’s disgusting pot stench is keeping tourists away

 It’s not just prissy European tennis players who can’t stand it. Every single person who visits New York City is disgusted by our unofficial new scent: marijuana.

And the truth is, so are most sane New Yorkers.

As The Post reported on Friday’s front page, everywhere you go in the five boroughs now reeks of pot. Expense-account restaurants such as Nobu 57 and ritzy stores like Saks Fifth Avenue have the musty whiff of a college dorm room. Puffing stoners are turning the subway’s 123 into CBD.

Even the US Open in Flushing Meadows is practically an open-air drug market.

Greek tennis player Maria Sakkari, who lost in the first round of the grand slam this week, told reporters she was distracted by something she sniffed during the match.

“It was weed,” the No. 8 player in the world said. “The smell, oh, my gosh.”

German ace Alexander Zverev spoke of blunts more bluntly: “Court 17 definitely smells like Snoop Dogg’s living room.”

Maria Sakkari
Greece’s Maria Sakkari was distracted by the smell of marijuana during her round one US Open loss.
AP

These are Europeans we’re talking about! Most Americans think of that party-hardy continent as far more freewheeling and permissive than the US when it comes to sex, drugs and booze consumption. Well, we’ve shocked ‘em all this time.

Ever since NYC reopened to international tourists, put-off visitors have commented on our putrid fragrance. They’d grown accustomed to our summers of roasting garbage, but it’s the pot smoke that makes them dry heave. 

Recently, a friend visiting from London succinctly summarized his trip to me.

“The magic is gone,” he said.

His problems? As a theater industry professional, he was dismayed to find that Times Square, which was an urban Disneyland just a few years ago, has gone back to being a seedy and uncomfortable mosh pit that’s littered with drugs.

And, like everybody else, he was appalled by the constant smell of cannabis that hovers over NYC like the fog from “Scooby-Doo.”

“It’s an aroma that keeps me absent from the city,” he said.

Most New Yorkers are fed up with the inescapable stench of lawlessness, too, but refrain from saying so for fear of being shouted at by progressive friends. We are, after all, a city that hates common sense.

Kathy Hochul and Eric Adams, Gov. Cheech and Mayor Chong, did not help matters by all but cutting the ribbons for the ubiquitous illegal pot shops with their shrugs and look-the-other-way attitude. Early on Adams told High Times, “Enjoy yourself, light up, but most importantly — spend some money.” 

Mayor Harold and Gov. Kumar have changed their tune in the past several months, saying they’re cracking down on illicit activity by threatening landlords with at least $10,000 fines.

It doesn’t seem to be working, you guys. 

Another Brit who was in town last month said he “was confused by how so many of these new shops and ‘delis’ were able to so brazenly operate in full view of the public.” 

So am I! So is everybody! 

Come to the East Village, where I live. It’s easier to buy a joint than a bagel.

New York’s lefty politicians love nothing more than to be emptily self-righteous — smoke all the marijuana ya want, come all ye migrants, congestion pricing — and then take zero responsibility for the obvious consequences. 

But as our city gets higher and higher, it will descend ever lower on tourists’ lists of places to go.

https://nypost.com/2023/09/01/nycs-disgusting-pot-stench-is-keeping-tourists-away/

Novo Integrated: Compliance Review Affirmed for Completion of Debt Funding Transaction

 Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the "Company" or "Novo"), today announced the Company received an Underwriting Clearance Notice from RC Consulting Group LLC informing Novo that the underwriting analysis process and compliance review for the transaction between Novo and RC Consulting LLC in favor of SCP Tourbillion Monaco (the "Buyer"), dated April 26, 2023, has been affirmed and approved for completion resulting in the recommendation to proceed with the transaction as contemplated.

The affirming position has resulted in a "Clear to Close" status for the transaction of an unsecured 15-year $70,000,000 promissory note with the Buyer for debt funding of $57,000,000. The note provides for a yield (non-compounding) of 1.52% (zero coupon) per annum and a maturity date 15 years from the date of issuance. The Note is unsecured and there is no provision for the conversion of debt, issuance of any class of shares, or the grant of any warrants by the Company to the Buyer.

https://finance.yahoo.com/news/novo-integrated-sciences-receives-underwriter-200500259.html

BioLineRx Reports Significant Decrease in Losses and Promising Financial Stability

 BioLineRx (NASDAQ:BLRX) recently announced its financial results for the second quarter of 2022, revealing a significant decrease in losses compared to the same period last year. The company reported a quarterly loss of $(0.30) per ADS, marking a 1400% decrease from the $(0.02) per ADS loss reported in the previous year. This improvement is undoubtedly a positive sign for BioLineRx.

Looking at the company’s net loss for the six months ended June 30, 2022, we can see a noteworthy reduction. The net loss amounted to $12.4 million, a considerable improvement compared to the net loss of $17.0 million for the same period in the previous year. This indicates that BioLineRx has been successful in managing its expenses and narrowing its losses.

In terms of financial stability, BioLineRx seems to be in a favorable position. The company currently holds $32.8 million in cash and equivalents. With this amount, BioLineRx is projected to have sufficient funds to sustain its operations until the first half of 2024. This financial stability provides a promising outlook for the company’s future endeavors.

https://beststocks.com/biolinerx-reports-significant-decrease-in-los/

Wedbush adds Geron to Best Ideas List, joining Ascendis, MoonLake

Wedbush has added Geron (GERN) to its Best Ideas List, citing a recent sell-off in shares and its high acquisition potential.

Patient Remote Monitoring and Constitutional Rights: Avoiding a Slippery Slope

 Our digitally connected world has created new opportunities - and potential perils - at the nexus of medical care and patient rights. Telemedicine played a huge role during the COVID pandemic, helping medical providers at least stay nominally connected to their patients, allowing for remote exams, prescription checks, and the like. 

But the same technology can become a tool that intrudes on the provider-patient relationship and medical privacy. Law enforcement can use it to monitor patients to whom doctors prescribe legal pain medication for legitimate purposes under the false presumption that patients will misuse them. That can inflict even more harm on a population of patients already collateral damage in America’s war on drugs.

Of course, advances in telemedicine technology and techniques were one of the few bright spots during the pandemic, and those provider-patient relationships remained voluntary and took place under the privacy protections afforded under the Health Insurance Portability and Accountability Act (HIPAA). 

But now, the ongoing controversy over opioid prescriptions and use has fueled interest by some in Congress to ask the Government Accountability Office (GAO) to study the possibilities on the “use of remote monitoring with respect to individuals who are prescribed opioids." That GAO study provision can be found in Section 118 of the Support for Patients and Communities Reauthorization Act, which passed the House Energy and Commerce Committee by a 49-0 vote on July 19.

There has been a wealth of literature on remote monitoring of patients for the outpatient management of opioid use disorder, including addiction specialists tapering their methadone patients gradually off of the drug in a way that avoids withdrawal symptoms. This is because, with the advent of telemedicine, it is hoped that doctors can manage all sorts of conditions remotely using sensing devices without the patients having to come to the doctor's office. 

The research is not limited to opioid monitoring. Technologies to remotely monitor blood pressure, EKGs, oxygenation, and more are either already available or soon will be. Private technology companies, funded by venture capital, continue to developthese devices, responding to the growing market for telehealth services. 

The government's only role here is to remove the 19th and 20th-century regulatory relics that stunt the growth of telehealth services. These are welcome developments, but we must never lose sight of the potential for the compromise or even abuse of such collected and stored data.

The recent bill’s GAO study requirement is a solution in search of a problem. There is no need for legislation to fund studies to remotely monitor opioid use since these studies are already being done and are well underway. As such, the GAO study requirement in the bill appears to be a form of legislative political theater aimed at showing concern for the opioid overdose problem. 

Moreover, the wording of the study language is too broad. It doesn't talk about remote monitoring for treating opioid use disorder or dependency, but just remote monitoring of patients on opioids. Such expansive language can lead to unintended and harmful consequences. 

Despite abundant public data to the contrary, most lawmakers believe that all these people accessing fentanyl, cocaine, meth, and Tranq on the black market are the products of doctors prescribing opioids to their patients to treat their pain. That misinformation is, in many ways, at the heart of the problem in our public debate on how to deal responsibly with opioids. 

A government-sanctioned study like the proposed one by GAO will no doubt show that, given current or projected technologies, it is possible to remotely monitor how patients use opioids through their physiological responses. With such data in hand, misinformed anti-opioid crusaders in Congress will then take the next "logical" step - legislation requiring all patients prescribed opioids for any reason to be remotely monitored (another example of "cops practicing medicine.") 

This will intimidate health care practitioners into further curtailing opioid prescribing to their patients in pain. This simply exacerbates the misery that state and federal opioid prescribing policies have already inflicted on them that is driving many to suicide and some to homicide.

We already live in an over-surveilled country as it is, courtesy of draconian, sweeping laws like the PATRIOT Act and the FISA Amendments Act, along with the proliferation of automated license plate readers, facial recognition technology, etc. Such laws and technologies have badly compromised our privacy in our personal communications, and the last thing we need is a perversion of telemedicine technology to further compromise the already-endangered medical provider-patient relationship.

Jeffrey A. Singer, MD practices general surgery in Phoenix, Arizona, and is a senior fellow at the Cato Institute; Patrick G. Eddington is a senior fellow at the Cato Institute.

https://www.realclearhealth.com/blog/2023/08/31/patient_remote_monitoring_and_constitutional_rights_avoiding_a_slippery_slope_976700.html

Proximal Liars

 When the virologist Kristian Andersen testified before the U.S. House Select Subcommittee on the Covid Pandemic this summer, he was asked to explain a seeming contradiction between his public and private statements about the origins of Covid.

In March 2020, as one of the authors of a study about the “proximal origins” of Covid published in Nature Medicine, Andersen stated that evidence demonstrated that Covid had not emerged from a laboratory but rather from another species, after which it crossed over into humans. Although an earlier draft of the paper left some room for the possibility that Covid might have come from a lab leak, the published version stated flatly that “any type of laboratory-based scenario” was not plausible.

In fact, as internal messages among scientists later revealed, Andersen and his colleagues didn’t have anywhere near this level of certainty, either before or after the paper was published. On a Slack forum of scientists convened by Anthony Fauci, Andersen himself wrote, “Accidental escape [from a lab] is in fact highly likely—it’s not some fringe theory.” He had told Fauci the same thing just a few weeks earlier. Andrew Rambaut, a biologist from the University of Edinburgh also on the Slack forum, said, “I literally swivel day by day thinking it is lab escape or natural.” A few weeks later, the paper was published. How had Andersen and his colleagues moved off their position of doubt about Covid’s origins so quickly?

The question matters because the “proximal origin” paper became the ur-text for shutting down any further exploration of the idea that Covid might have emerged from a laboratory in Wuhan. It also conveniently shut down any discussion of the possibility that China and, by implication, the United States’ scientific funding apparatus—which had subsidized controversial “gain of function” research in Wuhan—were responsible.

And yet the only message from the designated scientific leaders at the time was that anything other than natural origins was rank speculation at best and harmful conspiracy-theorizing at worst. Speaking in the White House press briefing room, Fauci assured the public that the data from the proximal-origins study were “totally consistent with a jump of a species from an animal to a human.” Francis Collins of the National Institutes of Health posted a message on the NIH website declaring, “This study leaves little room to refute a natural origin for Covid-19.”

Media outlets immediately ran with the story, citing the paper as definitive proof that the lab-leak hypothesis was little more than a conspiracist’s fever dream. Facebook moved swiftly to censor posts that referenced lab-leak theories. Cable-news hosts denounced mention of lab leaks as conspiracy-mongering. Joy Reid declared the lab-leak theory “debunked bunkum,” and her fellow MSNBCers Joe Scarborough and Nicole Wallace called it a “conspiracy theory.” On CNN, Drew Griffin claimed there was “zero proof” behind the lab-leak “conspiracy theory,” later claiming, incorrectly, that it had been “widely debunked.” The New York Times even chided Senator Tom Cotton for raising the possibility of a lab leak, calling it a “fringe” idea that encouraged unhealthy thought patterns. As Andersen watched the media attention lavished on his and his colleagues’ work, he wrote to a fellow scientist, “We RUUUUUUULE. That’s tenure secured, right there.”

Tenure might have been secured for Andersen, but public trust in the scientific establishment has since plummeted. Scientists who had been uncertain about the origins of Covid nevertheless deliberately obfuscated and misled reporters to craft a narrative that suited their political ends. One of Andersen’s colleagues had warned him privately about “the shit show that would happen if anyone serious accused the Chinese of accidental release,” and Andersen agreed, noting, “I hate when politics is injected into science—but it’s impossible not to, especially given the circumstances.” An astonishingly incurious media were more than happy to help them.

The crucial media organ for embedding the narrative that the lab-leak argument was mere conspiracy was the New York Times. At the time, the paper’s Covid reporter, Donald McNeil Jr., was pursuing the story, repeatedly asking Andersen for comment and explanation of possible origins, including a lab leak. Andersen boasted about misleading McNeil. “Can’t ignore him and can’t just give him the scientific story,” he wrote a colleague. “That would only lead to follow up question.” He added, “I’m hoping that by including ‘extremely busy’ I’ll also be able to deflect requests for a call—and also gives me a get out of jail card for ignoring potential request.”

McNeil at least attempted to pursue the lab-leak hypothesis. When he was abruptly forced to resign from the Times over a trumped-up claim of making a racist remark, McNeil was replaced by Apoorva Mandavilli, who immediately fell into line with the approved narrative. In May 2021, she tweeted, “Someday we will stop talking about the lab leak theory and maybe even admit its racist roots. But alas, that day is not yet here.”

The Times continued to endorse the narrative. Even when some of Fauci’s emails were leaked to the press in 2021, showing far more ambiguity about the origins debate, the Times gave space to Andersen to defend scientists’ behavior as merely being the scientific process at work: “Overall, this is a textbook example of the scientific method where a preliminary hypothesis is rejected in favor of a competing hypothesis after more data became available and analyses are completed.” But given the behavior of Chinese officials in Wuhan, including barring any independent investigations of the laboratory, how could a full analysis of the possibility ever have occurred?

As recently as mid-July 2023, the Times was still defending Andersen and his colleague after their House testimony. “Two world-renowned virologists appeared on Capitol Hill on Tuesday and delivered a pointed defense of their findings that the coronavirus pandemic was natural in origin, and told skeptical Republicans that Dr. Anthony S. Fauci did not exert influence over a scientific paper they wrote to that effect,” the lede to the Times story read.

Other outlets, such the Atlantic, have indulged in convenient semantical arguments to downplay what the leaked Slack messages revealed. “From the start, the problem has been that a ‘lab leak’ could mean many things,” Daniel Engber wrote. He criticized the congressional hearing, saying it “gestures not toward the true origin of Covid, but toward the origin of the origins debate.” This is a rather tortured way of avoiding the topic of what the scientists in question did wrong. Rather than say, “We’re not sure but here are the possibilities for the origins of Covid,” the community closed ranks and declared the lab-leak theory verboten.

Also left unexplored by mainstream media outlets were potential conflicts of interest among the authors of the proximal-origins paper. For example, while Andersen was seeking guidance from Fauci about how to frame the arguments in the paper, he was also waiting to find out whether Fauci would approve an $8.9 million research grant he had submitted. Fauci approved Andersen’s grant four days after the proximal-origins paper was published. One would think an intrepid science reporter might want to find out whether this was merely coincidence or in fact a conflict of interest.

Of course, we know about any of these internal scientific debates only because Republicans in the House subpoenaed the Slack conversations and emails. They may have done so for their own political purposes, but that still raises the question of why journalists, who pride themselves on being the country’s truth-seekers, so quickly became eager, incurious purveyors of what those in power told them to say during the pandemic.

Contemporary media are siloed not only along partisan lines but also along elite and non-elite lines—in the case of the Covid origins debate, the Times and other mainstream outlets doubled down on serving as the mouthpiece of the elite. They could have examined their own editorial mistakes; taken responsibility for failing to realize they were being manipulated by the scientists; and vowed to do better in future by exercising a more vigorous journalistic skepticism about all sources, not merely the ones who question the newspaper’s preferred narrative. They could have done their jobs better. Instead, they aided and abetted the undermining of the public’s trust in scientific institutions. But at least they helped a bald-faced liar get tenure.

https://www.commentary.org/articles/christine-rosen/covid-origins-kristian-andersen-media-coverage/

Humana sues U.S. government to block Medicare clawback rule

 Humana on Friday sued the U.S. government to block a Biden administration policy that would let Medicare claw back billions of dollars of payments to insurers.

The lawsuit in federal court said the Centers for Medicare and Medicaid Services "did not even try" to justify its more aggressive approach toward determining whether private Medicare Advantage plans for people age 65 and older were overpaid.

Humana's lawsuit challenges a rule announced on Jan. 30 that would let the government recoup payments when audits uncover charges for diagnoses that are not in patients' medical records.

The administration said the increased oversight could help the government collect as much as $4.7 billion over 10 years.

Humana said the rule was "arbitrary and capricious," and threatened "unpredictable consequences for Medicare Advantage organizations and the millions of seniors who rely on the Medicare Advantage program for their healthcare."

CMS is part of the U.S. Department of Health and Human Services. The agency did not immediately respond to a request for comment.

Humana filed its lawsuit with the U.S. District Court in the Northern District of Texas, which has in recent years been sympathetic toward some challenges to federal rulemaking.

The case was assigned to U.S. District Judge Reed O'Connor, a Fort Worth judge who previously declared unconstitutional all or part of the Affordable Care Act, also known as Obamacare.

https://finance.yahoo.com/news/humana-sues-block-medicares-clawbacks-153147681.html